Neosomeplus - Exosomes derived from immortalized Neonatal Stem Cells

NeoProgen is a pre-clinical stage company developing human neonatal heart-derived Medicinal Signaling Cells (nMSCs) and an exosome-based product for tissue repair and regeneration for the treatment of heart failure (HF) and other inflammatory diseases.